Shandong Buchang Pharmaceuticals Co Ltd Net Asset Quality Index
Shandong Buchang Pharmaceuticals Co Ltd net asset quality index. Shandong Buchang Pharmaceuticals Co Ltd (603858) has a Net Asset Quality Index of 51.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥19.57 Billion minus total liabilities of CN¥9.50 Billion yields net assets of CN¥10.07 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Shandong Buchang Pharmaceuticals Co Ltd (603858) net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Shandong Buchang Pharmaceuticals Co Ltd (2011–2024)
Net asset quality index of Shandong Buchang Pharmaceuticals Co Ltd from 2011 to 2024. This chart shows how Shandong Buchang Pharmaceuticals Co Ltd's Net Asset Quality Index has evolved across 14 annual periods from 2011 to 2024. As of September 2025, the index stands at 51.5%, representing net assets of CN¥10.07 Billion against total assets of CN¥19.57 Billion CNY. Check 603858 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Shandong Buchang Pharmaceuticals Co Ltd Net Asset Quality Index by Year (2011–2024)
Shandong Buchang Pharmaceuticals Co Ltd net asset quality index by year from 2011 to 2024. The table below presents the year-by-year Net Asset Quality Index for Shandong Buchang Pharmaceuticals Co Ltd from 2011 to 2024, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Shandong Buchang Pharmaceuticals Co Ltd (603858) total market value.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 50.7% | CN¥9.81 Billion | CN¥19.33 Billion | CN¥9.52 Billion | ▼ -3.7 pp |
| 2023 | 54.5% | CN¥11.38 Billion | CN¥20.89 Billion | CN¥9.52 Billion | ▼ -1.5 pp |
| 2022 | 55.9% | CN¥12.28 Billion | CN¥21.95 Billion | CN¥9.68 Billion | ▼ -4.3 pp |
| 2021 | 60.2% | CN¥14.45 Billion | CN¥23.99 Billion | CN¥9.54 Billion | ▼ -0.1 pp |
| 2020 | 60.3% | CN¥13.81 Billion | CN¥22.89 Billion | CN¥9.08 Billion | ▼ -4.7 pp |
| 2019 | 65.1% | CN¥13.79 Billion | CN¥21.19 Billion | CN¥7.40 Billion | ▼ -4.1 pp |
| 2018 | 69.2% | CN¥13.86 Billion | CN¥20.03 Billion | CN¥6.17 Billion | ▲ +0.3 pp |
| 2017 | 68.9% | CN¥13.22 Billion | CN¥19.20 Billion | CN¥5.98 Billion | ▲ +0.8 pp |
| 2016 | 68.1% | CN¥12.71 Billion | CN¥18.67 Billion | CN¥5.96 Billion | ▲ +22.0 pp |
| 2015 | 46.1% | CN¥7.26 Billion | CN¥15.76 Billion | CN¥8.50 Billion | ▼ -2.8 pp |
| 2014 | 48.9% | CN¥4.45 Billion | CN¥9.10 Billion | CN¥4.65 Billion | ▼ -12.9 pp |
| 2013 | 61.7% | CN¥4.28 Billion | CN¥6.94 Billion | CN¥2.66 Billion | ▼ -9.2 pp |
| 2012 | 71.0% | CN¥4.02 Billion | CN¥5.67 Billion | CN¥1.65 Billion | ▲ +7.9 pp |
| 2011 | 63.1% | CN¥2.80 Billion | CN¥4.44 Billion | CN¥1.64 Billion | — |